CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 14 No. 3 4
Lifetime smokers most vulnerable 

Alcohol, Obesity, and Smoking Risk Factors for HCC

By JAMES L. ABBRUZZESE, MD
The University of Texas M. D. Anderson Cancer Center | March 2, 2005

BOSTON-Alcohol, obesity, and tobacco are all independent risk factors for hepatocellular carcinoma (HCC), according to a case-control study presented at the 54th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD abstract 253). Jorge A. Marrero, MD, of the University of Michigan Health System, Ann Arbor, found lifetime smokers were most vulnerable, and suggested lifetime exposure to more than one risk factor would significantly raise a person's risk of liver cancer. "Tobacco, alcohol(Drug information on alcohol), and obesity interact synergistically to increase the risk of hepatocellular carcinoma," he said. The study matched 65 consecutive HCC patients with two control groups: 65 patients with cirrhosis but no signs of HCC, and 65 healthy persons with normal liver tests and no history of liver disease. Each group had an aver age age in the mid-50s and more men than women. The investigators used validated questionnaires to gather information on lifetime tobacco and alcohol use, which were measured in pack-years and kilogram-years, respectively. Body mass index (BMI) was recorded when the patients were interviewed. Lifetime exposure to alcohol and tobacco was significantly higher in HCC patients and in cirrhotic patients: 73% of the cancer group and 83% of the cirrhotic patients, but only 5% of the healthy controls, were former drinkers; 12% of the cancer patients and 6% percent of the controls, but none of the cirrhotic patients, were current drinkers. Only 2% of those with healthy livers reported being current smokers; the same percentage identified themselves as former smokers. Among HCC patients, however, 63% said they used to smoke and 18% were current smokers. In the cirrhotic group, 37% were former smokers and 29% continued to smoke. Significant Predictors for HCC Dr. Marrero and his colleagues calculated that alcohol intake greater than 6 kilogram-years of ethanol (defined as 20 g/d for 15 years) and tobacco use greater than 15 pack-years were significant predictors of HCC. The average total alcohol consumption was 34 kilogram-years for the cancer patients, 24 for the cirrhosis patients, and 5 for the healthy controls. Cancer patients had double the lifetime tobacco exposure of cirrhotic patients- 31 pack-years vs 15. In contrast, the healthy group's exposure was 2 pack- years on average. The HCC patients also smoked longer than the cirrhotic patients (22 years vs 17) and drank longer (29 years vs 22). Both groups had much longer exposures than the healthy people. HCC risk increased 2.6-fold with moderate exposure to tobacco, but shot up 8.2-fold with heavy exposure, Dr. Marrero said. Similarly, the risk increased almost 3-fold with moderate alcohol consumption, but almost 4.5-fold with heavy consumption. Average BMI was 32 for the HCC patients and 28 for the cirrhosis patients. Among heavy smokers, Dr. Marrero said, HCC risk increased almost 5-fold in people with a BMI greater than 30. Yet obesity increased risk only 1.5-fold in people who did not smoke. While smoking and drinking tripled risk for lean patients, no significant interaction was found between alcohol by itself and BMI. Dr. Marrero called for prospective studies toward developing a method to stratify cirrhotic patients into highand low-risk groups for HCC.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





An Annual Review of Gastrointestinal Cancers


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy